Quantcast

Latest Laval Stories

2011-07-11 07:00:00

PARIS, July 11, 2011 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) announced today the strategic divestiture of its dermatology business, Dermik, to Valeant Pharmaceuticals International Inc. (NYSE/TSX: VRX) ("Valeant"), for a total cash consideration of US $425 million. Valeant is a pharmaceutical company focused on the neurology and dermatology therapeutic areas, based in Mississauga, Ontario, Canada. (Logo: http://photos.prnewswire.com/prnh/20110616/NY20158LOGO ) Dermik has a...

2011-03-16 14:47:40

Researchers under the supervision of Universit© Laval professor Ga©tan Laroche have developed the very first permanent anti-fog coating. Dr. Laroche and his colleagues present in the online edition of Applied Materials and Interfaces the details of this innovation which could eliminate, once and for all, the fog on eyeglasses, windshields, goggles, camera lenses, and on any transparent glass or plastic surface. Fog forms on a surface when water vapor in the air condenses in fine...

2011-03-14 06:00:00

LAVAL, QC, March 14 /PRNewswire-FirstCall/ - Labopharm announced today that Mark D'Souza, the Corporation's current Chief Financial Officer, has been elected President and Chief Executive Officer of Labopharm and a member of the board of directors. "We are delighted to have Mark's knowledge and experience to lead the Corporation forward," said Santo J. Costa, Labopharm's Chairman. Mr. D'Souza replaces James Howard-Tripp as President and Chief Executive Officer. Mr. Howard-Tripp will also...

2011-02-24 06:00:00

LAVAL, QC, Feb. 24 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today reported its progress and financial results for the fourth quarter and year ended December 31, 2010. All figures are in Canadian dollars unless otherwise stated. Commercial activities related to the U.S. launch of OLEPTRO(TM) by Angelini Labopharm, LLC continue. As of December 31, 2010, OLEPTRO(TM) sales representatives had completed more than 75,000 physician visits and distributed more than 150,000...

2011-02-10 09:40:00

- Management to discuss fourth quarter progress and financial results - LAVAL, QC, Feb. 10 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced that it will host a conference call on Thursday, February 24, 2011 at 8:30 a.m. (ET) to discuss its fourth quarter 2010 progress and financial results. Labopharm will report its fourth quarter 2010 financial results via news release before the markets open the same day. To access the conference call by telephone, dial...

2011-01-25 07:00:00

- Mary Anne Heino Confirmed as President, Angelini Labopharm; Dr. Jeffrey Dayno Appointed President, Labopharm USA - LAVAL, QC, Jan. 25 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced the confirmation of Mary Anne Heino's appointment as President, Angelini Labopharm, LLC. Jeffrey M. Dayno, M.D., currently Labopharm's Chief Medical Officer, has been appointed President, Labopharm USA, Inc., replacing Ms. Heino. "As acting President of Angelini Labopharm, Mary...

2011-01-20 08:46:00

- Company Advancing Partnership Discussions and Preparing for Canadian Launch - LAVAL, QC, Jan. 20 /PRNewswire/ - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced that Health Canada's Therapeutic Products Directorate (TPD) has approved OLEPTRO(TM) (trazodone hydrochloride Extended Release Tablets), a novel once-daily formulation of the antidepressant trazodone, for the symptomatic relief of Major Depressive Disorder (MDD) in adults. OLEPTRO(TM) acts as a serotonin antagonist reuptake...

2011-01-03 06:00:00

LAVAL, QC, Jan. 3 /PRNewswire/ - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced that, through its wholly owned subsidiary, Labopharm Europe Limited, it has monetized the expected future royalty payment stream for RYZOLT(TM) (once-daily tramadol). To facilitate the transaction, Labopharm has further amended its license agreement with Purdue Pharma Products, L.P. for RYZOLT(TM) for the U.S. The second amendment to the license agreement provides for the restructuring of the royalty...

2010-12-31 15:30:00

LAVAL, QC, Dec. 31 /PRNewswire/ - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced that on December 29, 2010 it received notice from the Listings Qualifications Department of The Nasdaq Stock Market (Nasdaq) that the closing bid price of the Company's common shares was below the minimum requirement of US$1.00 per share for 30 consecutive business days and the Company was therefore not in compliance with Nasdaq Listing Rules.  The notification has no impact at this time on...

7d576f48b5f7fc80f321c8917711653a
2010-12-06 10:55:00

Researchers at Universit© Laval, in collaboration with Nova Scotia Agricultural College, have discovered what causes Christmas tree needles to drop off, and how to double the lifespan of Christmas trees in homes. The authors presented their findings in a recent issue of the scientific journal Trees. The researchers have identified a plant hormone"”ethylene"”responsible for needle loss in balsam fir. They made the discovery by placing fir branches in containers of water inside...


Word of the Day
bellycheer
  • Good cheer; viands.
  • To revel; to feast.
The word 'bellycheer' may come from 'belle cheer', "good cheer".
Related